Which are the causes of Sarcoidosis?

The exact cause of Sarcoidosis remains unknown, though current scientific consensus suggests it arises from an exaggerated immune response to an unidentified environmental trigger in genetically susceptible individuals.

The Etiology of Sarcoidosis

In Sarcoidosis, the body’s immune system—which normally protects us from invaders—becomes overactive. It begins to attack the body's own healthy tissues, forming tiny clumps of inflammatory cells called granulomas. Think of these granulomas like "scar tissue knots" that can interfere with the normal function of organs, most commonly the lungs and lymph nodes.

Genetic and Environmental Factors

While no single "Sarcoidosis gene" has been identified, research indicates that certain human leukocyte antigen (HLA) genes play a role in how the immune system recognizes foreign substances. However, genetics alone do not cause the disease. Environmental triggers are likely required to "flip the switch." Researchers are investigating various potential triggers, including:

• Infectious agents, such as certain bacteria (e.g., mycobacteria or propionibacteria).


• Inorganic particles, such as metallic dust or silica.


• Occupational exposures in specific industrial settings.

Distinguishing Causes from Risk Factors

It is important to distinguish between a cause and a risk factor. A cause is the direct agent triggering the disease, which remains elusive in Sarcoidosis. Risk factors are characteristics that increase the likelihood of developing the condition, such as age (most common between 20 and 40), ethnicity (higher incidence and severity in African Americans), and family history.

Ongoing Research

Current medical research is focused on identifying the specific "antigen" that initiates this inflammatory cascade. By utilizing advanced genomic sequencing and immunological profiling, scientists hope to clarify why the immune system in patients with Sarcoidosis fails to turn off once the initial trigger is encountered. Understanding this mechanism is the key to developing targeted therapies that can stop granuloma formation without suppressing the entire immune system.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Foundation for Sarcoidosis Research (FSR)


• Online Mendelian Inheritance in Man (OMIM)